Pre-Market Money Movers

by @tabber

NOV 17, 2026

Scorecard: 2/2 — both calls held into the close

Monday’s two pre-market calls went 2/2. Summit and CoreWeave both closed within a point of their morning prints.

Scorecard
In this brief: 2 sections 1 min read
    • • FDA issued a Complete Response Letter for ivonescimab — no statistically significant overall-survival gain in the HARMONi trial.
    • • Opened $12.71, traded $11.53–$13.28 on ~24.4M shares.
    • • Near-term U.S. launch of Summit’s flagship drug is halted; the company will engage with the FDA on next steps.
    • • Neocloud selloff extended on worries Nvidia’s new leadership may fund AI infrastructure firms more cautiously after CEO Jensen Huang’s resignation.
    • • Opened $49.36, traded $48.59–$52.06 on ~53.1M shares.
    • • Nebius (-5.5%) and IREN (-5.3%) fell in step; CoreWeave also carries reported $4B+ loan talks and a new equity-sale program.
Useful?